412 related articles for article (PubMed ID: 9286230)
1. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
[TBL] [Abstract][Full Text] [Related]
2. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
Yamaoka Y; Kodama T; Kashima K; Graham DY
J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of Western Blot method for the detection of antibodies to Helicobacter pylori antigens in patients with gastric carcinoma and cases with epigastric complaints].
Güdücüoğlu H; Berktaş M; Bozkurt H; Toka Ozer T; Bulut G; Oztürk O; Ilhan M
Mikrobiyol Bul; 2010 Jan; 44(1):21-8. PubMed ID: 20455395
[TBL] [Abstract][Full Text] [Related]
4. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany.
Miehlke S; Kirsch C; Agha-Amiri K; Günther T; Lehn N; Malfertheiner P; Stolte M; Ehninger G; Bayerdörffer E
Int J Cancer; 2000 Aug; 87(3):322-7. PubMed ID: 10897035
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases.
Basso D; Navaglia F; Brigato L; Piva MG; Toma A; Greco E; Di Mario F; Galeotti F; Roveroni G; Corsini A; Plebani M
Gut; 1998 Aug; 43(2):182-6. PubMed ID: 10189841
[TBL] [Abstract][Full Text] [Related]
6. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.
Sezikli M; Guliter S; Apan TZ; Aksoy A; Keles H; Ozkurt ZN
Int J Clin Pract; 2006 Oct; 60(10):1239-43. PubMed ID: 16669834
[TBL] [Abstract][Full Text] [Related]
7. CagA and VacA: virulence factors of Helicobacter pylori in Thai patients with gastroduodenal diseases.
Mahachai V; Tangkijvanich P; Wannachai N; Sumpathanukul P; Kullavanijaya P
Helicobacter; 1999 Sep; 4(3):143-7. PubMed ID: 10469187
[TBL] [Abstract][Full Text] [Related]
8. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
9. Association between Helicobacter pylori VacA antigens and gastric cancer depends on the detection method used: immunoblot versus neutralization of the vacuolating activity of VacA.
Ayala G; Torres-Mena J; López-Carrillo L
J Med Microbiol; 2008 Jan; 57(Pt 1):9-14. PubMed ID: 18065661
[TBL] [Abstract][Full Text] [Related]
10. Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.
Donati M; Moreno S; Storni E; Tucci A; Poli L; Mazzoni C; Varoli O; Sambri V; Farencena A; Cevenini R
Clin Diagn Lab Immunol; 1997 Jul; 4(4):478-82. PubMed ID: 9220168
[TBL] [Abstract][Full Text] [Related]
11. Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.
Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Wadström T; Andersen LP
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):220-5. PubMed ID: 17567283
[TBL] [Abstract][Full Text] [Related]
12. VacA seropositivity is not associated with the development of gastric cancer in a Japanese population.
Shimoyama T; Neelam B; Fukuda S; Tanaka M; Munakata A; Crabtree JE
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):887-90. PubMed ID: 10514122
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile.
Figueroa G; Troncoso M; Toledo MS; Faúndez G; Acuña R
J Med Microbiol; 2002 Apr; 51(4):300-304. PubMed ID: 11926734
[TBL] [Abstract][Full Text] [Related]
14. Seropositivity against Helicobacter pylori CagA in Turkish gastric cancer patients.
Gürbüz AK; Ozel AM; Yazgan Y; Günay A; Ozdemir S; Demirtürk L; Emekdaş G
J Clin Gastroenterol; 2001; 33(5):389-92. PubMed ID: 11606855
[
